BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10930425)

  • 1. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation.
    Koundrioukoff S; Jónsson ZO; Hasan S; de Jong RN; van der Vliet PC; Hottiger MO; Hübscher U
    J Biol Chem; 2000 Jul; 275(30):22882-7. PubMed ID: 10930425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase delta or DNA ligase I.
    Riva F; Savio M; Cazzalini O; Stivala LA; Scovassi IA; Cox LS; Ducommun B; Prosperi E
    Exp Cell Res; 2004 Feb; 293(2):357-67. PubMed ID: 14729473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
    Funk JO; Waga S; Harry JB; Espling E; Stillman B; Galloway DA
    Genes Dev; 1997 Aug; 11(16):2090-100. PubMed ID: 9284048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
    J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
    Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
    J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.
    Flores-Rozas H; Kelman Z; Dean FB; Pan ZQ; Harper JW; Elledge SJ; O'Donnell M; Hurwitz J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8655-9. PubMed ID: 7915843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of human DNA polymerase lambda by the cyclin-dependent kinase Cdk2/cyclin A complex is modulated by its association with proliferating cell nuclear antigen.
    Frouin I; Toueille M; Ferrari E; Shevelev I; Hübscher U
    Nucleic Acids Res; 2005; 33(16):5354-61. PubMed ID: 16174846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the regulation of DNA synthesis by cdk2, Cip1, and licensing factor.
    Yan H; Newport J
    J Cell Biol; 1995 Apr; 129(1):1-15. PubMed ID: 7698977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2.
    Fukami-Kobayashi J; Mitsui Y
    Exp Cell Res; 1999 Feb; 246(2):338-47. PubMed ID: 9925749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen.
    Jónsson ZO; Hindges R; Hübscher U
    EMBO J; 1998 Apr; 17(8):2412-25. PubMed ID: 9545252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early events in DNA replication require cyclin E and are blocked by p21CIP1.
    Jackson PK; Chevalier S; Philippe M; Kirschner MW
    J Cell Biol; 1995 Aug; 130(4):755-69. PubMed ID: 7642695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.
    Swanson C; Ross J; Jackson PK
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7796-801. PubMed ID: 10884410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation.
    Henneke G; Koundrioukoff S; Hübscher U
    Oncogene; 2003 Jul; 22(28):4301-13. PubMed ID: 12853968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.
    Sever-Chroneos Z; Angus SP; Fribourg AF; Wan H; Todorov I; Knudsen KE; Knudsen ES
    Mol Cell Biol; 2001 Jun; 21(12):4032-45. PubMed ID: 11359910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
    Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.